Read here latest news, events news, current affairs, recene incidents by Health Desk on financialexpress.com . Check here exclusive stories, blogs, bylines, articles written by Health Desk on breaking ...
Retail prices for 39 new drug formulations have been fixed under the DPCO, 2013, to improve access to affordable medicines ...
Business Insider Africa on MSN
Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies
Novo Nordisk is launching a cheaper authorised version of its blockbuster diabetes drug Ozempic in South Africa, intensifying ...
Global GLP-1 Receptor Agonists Market to grow from USD 18.4 billion in 2024 to USD 41.5 billion by 2030 as diabetes treatment, obesity care, cardiovascular risk reduction, oral drug innovation, and ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...
A 2026 modeling study presented at ICO 2026 in Mexico City estimates that 23–38% of Canadian cardiovascular deaths are linked ...
Compounded forms of semaglutide and tirzepatide were being sold by dozens of compounded pharmacies from August to October ...
Gamblers can now bet on how experimental drugs will perform in clinical trials—and if they’ll get FDA approval.
Biomed Industries Presents Promising Phase 2/3 Clinical Results of NA-921 for Rett Syndrome at Orphan Drug Summit 2026 ...
A law passed last year requires CT to petition the federal government for cheaper GLP-1 drugs. But the state is not moving ...
Glenmark Pharmaceuticals will pay nearly $29.7 million to resolve allegations that it participated in a coordinated scheme to inflate generic drug prices and reduce competition. The settlement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results